iBio, Inc. IBIO
NASDAQ IBIO
$0.82 +0.06 (+8.01%)
At close: Oct 20, 2026 · 4:00 PM EDT

iBio (IBIO) Acquisitions (2022)

Updated

iBio (IBIO) posted Acquisitions of $692,000 for FY2023 (year ended Jun 30, 2023).

Analysis

iBio (IBIO) Acquisitions (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -17.24 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 iBio 87.72 Mn -177.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 692,000.00
API Access

iBio Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=IBIO&period=max&api_key=YOUR_API_KEY